| APTOSE BIOSCIENCES |
| Kanada |
| Gesundheit |
| CA03835T4081 / A40YEP |
| LTI0 (Frankfurt) |
| FRA:LTI0, ETR:LTI0, LTI0:GR |
| - |
| https://www.aptose.com/ |
|
Aptose Biosciences Inc. is a clinical-stage biotechnology company focused on developing precision medicines to address unmet medical needs in oncology, primarily targeting hematological cancers. The company's pipeline features small molecule therapeu..
>Volltext.. |
| 3.69 Mio. EUR |
| 23.83 Mio. EUR |
| - |
| -21.18 Mio. EUR |
| -22.19 Mio. EUR |
| -9.08 EUR |
| 23.99 Mio. EUR |
| 3.5 Mio. EUR |
| -19.16 Mio. EUR |
| 0.44 |
| - |
| 5.08% |
| - |
| - |
| - |
| - |
| APTOSE BIOSCIENCES, APTOSE BIO |
| 08.04.26 |
|